Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(1 site)
United States
Wills Eye Hosital Glaucoma Dept., Philadelphia, Pennsylvania Last updated November 2025